CVE-2008-0838

Public Exploit

Description

Multiple cross-site scripting (XSS) vulnerabilities in the web administration interface in Sophos ES1000 and ES4000 Email Security Appliance 2.1.0.0 allow remote attackers to inject arbitrary web script or HTML via the (1) error and (2) go parameters to the login page.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 13.62% Top 10%
Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.securityfocus.com/archive/1/488206/100/0/threaded mailing list
http://www.securitytracker.com/id?1019427 vdb entry
http://www.sophos.com/support/knowledgebase/article/34733.html
http://www.securityfocus.com/bid/27813 vdb entry exploit
http://securityreason.com/securityalert/3673 third party advisory
http://www.infigo.hr/en/in_focus/advisories/INFIGO-2008-02-13
http://www.vupen.com/english/advisories/2008/0574 vdb entry
http://secunia.com/advisories/28961 third party advisory vendor advisory

Frequently Asked Questions

What is the severity of CVE-2008-0838?
CVE-2008-0838 has been scored as a medium severity vulnerability.
How to fix CVE-2008-0838?
To fix CVE-2008-0838, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2008-0838 being actively exploited in the wild?
It is possible that CVE-2008-0838 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~14% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.